ES2183373T3 - Esteres de tocoferol y su utilizacion en cosmetica y farmacia. - Google Patents

Esteres de tocoferol y su utilizacion en cosmetica y farmacia.

Info

Publication number
ES2183373T3
ES2183373T3 ES98925707T ES98925707T ES2183373T3 ES 2183373 T3 ES2183373 T3 ES 2183373T3 ES 98925707 T ES98925707 T ES 98925707T ES 98925707 T ES98925707 T ES 98925707T ES 2183373 T3 ES2183373 T3 ES 2183373T3
Authority
ES
Spain
Prior art keywords
acid
esters
ceramides
derivatives
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98925707T
Other languages
English (en)
Inventor
Frederic Bonte
Alex Saunois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LVMH Recherche GIE
Original Assignee
LVMH Recherche GIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LVMH Recherche GIE filed Critical LVMH Recherche GIE
Application granted granted Critical
Publication of ES2183373T3 publication Critical patent/ES2183373T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

La composición citada se caracteriza por contener al menos otro componente activo, en particular seleccionado entre el grupo constituido por A, B1, B6, B12, E, C, PP, ácido retinoico, retinal, retinol y sus ésteres, ácido salicílico y sus derivados, en particular sus sales o sus ésteres, ácido 2,5-dihidroxibenzoico, tocoferol y sus ésteres, en particular el fosfato de tocoferol, ácido asiático, ácido madecásico y sus ésteres glicosilados, asiaticósido, un extracto de Centella asiática, un extracto de Siegesbeckia orientalis, los oligómeros proantocianídicos, especialmente los obtenidos a partir de pepitas de uva y sus ésteres, en particular palmítico y esteárico, los derivados de ácido ascórbico, en particular el fosfato y sus sales, ácido eritórbico, oligoelementos, especialmente en forma de sal, en particular en forma de aspartato o de cloruro, tales como magnesio, selenio, zinc o cobre, los ácidos alfa-hidroxilados, especialmente el ácido málico, el ácido láctico y el ácido tártrico, y sus ésteres, en particular con alcoholes grasos, tales como alcohol estearílico, aminoácidos, en particular serina, treonina, citrulina, así como los aminoácidos constituyentes del NMF ("Natural Moisturizing Factor": K. Sakamoto, Cosmet. Toilet. (1984) 99(3), 109-117), las ceramidas, en particular las ceramidas 2, 3 ó 6 utilizadas solas o en mezcla, las fitoceramidas, en particular las extraídas del trigo, y los ecdisteroides, en particular la ecdisterona, y sus ésteres.
ES98925707T 1997-05-14 1998-05-14 Esteres de tocoferol y su utilizacion en cosmetica y farmacia. Expired - Lifetime ES2183373T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9705907A FR2763336B1 (fr) 1997-05-14 1997-05-14 Esters de tocopherol et leurs utilisations en cosmetique et pharmacie

Publications (1)

Publication Number Publication Date
ES2183373T3 true ES2183373T3 (es) 2003-03-16

Family

ID=9506875

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98925707T Expired - Lifetime ES2183373T3 (es) 1997-05-14 1998-05-14 Esteres de tocoferol y su utilizacion en cosmetica y farmacia.

Country Status (7)

Country Link
US (1) US6136851A (es)
EP (1) EP0983259B1 (es)
JP (1) JP4387464B2 (es)
DE (1) DE69807070T2 (es)
ES (1) ES2183373T3 (es)
FR (1) FR2763336B1 (es)
WO (1) WO1998051679A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY138883A (en) * 2000-08-29 2009-08-28 Government Of Malaysia As Represented By The Ministry Of Science Tehnology And Innovation Malaysia Use of asiatic acid for treatment of cencer
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
WO2003074019A1 (en) 2002-03-06 2003-09-12 Showa Denko K.K. Whitening cosmetic composition
AU2003224458A1 (en) * 2002-05-09 2003-11-11 Showa Denko K.K. Skin whitening external preparation
US6645514B1 (en) 2002-12-19 2003-11-11 Access Business Group International, Llc Increasing skin cell renewal with water-soluble Vitamin E
US20060233739A1 (en) * 2003-11-24 2006-10-19 Thornfeldt Carl R Treatment of mucocutaneous disorders through reversing chronic imflammation and barrier disruption
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US20060165769A1 (en) * 2004-09-30 2006-07-27 Hyatt John A Pharmaceutical formulations containing vitamin E TPGS molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US8242294B2 (en) 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
JOP20180077A1 (ar) 2007-06-19 2019-01-30 Kythera Biopharmaceuticals Inc تركيبات وطرق لحمض صفراوي تخليقي
US20080318870A1 (en) 2007-06-19 2008-12-25 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
MX2010010050A (es) * 2008-03-20 2011-03-15 Virun Inc Star Emulsiones que incluyen un derivado de polietilen glicol de tocoferol.
BRPI0909185A2 (pt) 2008-03-20 2015-08-25 Virun Inc Derivado de vitamina e e seus usos
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
FR2945442B1 (fr) * 2009-05-14 2012-08-03 Fabre Pierre Dermo Cosmetique Utilisation de delta-tocopheryl-glucide en tant qu'agent depigmentant.
US8969303B2 (en) * 2010-02-05 2015-03-03 First Tech International Limited Tocotrienol esters
EP2563164B1 (en) * 2010-03-23 2016-06-29 Virun, Inc. Nanoemulsion including sucrose fatty acid ester
WO2011162802A1 (en) 2010-06-21 2011-12-29 Virun, Inc. Compositions containing non-polar compounds
CA2783017C (en) 2010-08-12 2018-05-15 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
US20120237492A1 (en) 2011-02-18 2012-09-20 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
CA2863544C (en) 2012-02-10 2019-03-26 Virun, Inc. Beverage compositions containing non-polar compounds
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
JP2016050196A (ja) * 2014-08-29 2016-04-11 昭和電工株式会社 皮膚色改善剤及び皮膚色改善用組成物
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
WO2016044813A1 (en) 2014-09-18 2016-03-24 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
WO2020230726A1 (ja) * 2019-05-13 2020-11-19 昭和電工株式会社 大気汚染物質からの保護剤及び大気汚染物質からの保護用組成物
WO2022087735A1 (en) * 2020-10-28 2022-05-05 Hermay Labs Corporation Labile and coherent redox-silent analogues for vitamin e enhancement
CN119264094B (zh) * 2024-12-04 2025-08-29 上海克琴科技有限公司 生育酚衍生物及其制备方法和应用
CN120383579B (zh) * 2025-05-29 2026-07-10 无锡知妍生物科技有限公司 一种制备双生育酚壬二酸酯的方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES417893A1 (es) * 1973-08-14 1976-03-16 Andreu Sa Dr Procedimiento para la obtencion de esteres de du-alfa-toco-fero.
FR2314722A1 (fr) * 1975-06-19 1977-01-14 Etud Expl Marques Brevets Procede de preparation d'acetylsalicylate de tocol et homologues

Also Published As

Publication number Publication date
JP2002504098A (ja) 2002-02-05
JP4387464B2 (ja) 2009-12-16
WO1998051679A1 (fr) 1998-11-19
FR2763336A1 (fr) 1998-11-20
DE69807070T2 (de) 2003-07-24
US6136851A (en) 2000-10-24
EP0983259B1 (fr) 2002-08-07
DE69807070D1 (de) 2002-09-12
FR2763336B1 (fr) 1999-08-06
EP0983259A1 (fr) 2000-03-08

Similar Documents

Publication Publication Date Title
US10660838B2 (en) Composition and method for improving the appearance of skin
JP7285848B2 (ja) 化粧品における環状ペプチドの使用
US9833398B2 (en) Method of treating a skin condition and compositions therefor
CN104203210B (zh) 合欢提取物与对应局部合成物的化妆品应用
US7566464B2 (en) Cosmetic composition to accelerate repair of functional wrinkles
ES2865853T3 (es) Composición cosmética que comprende jalea real de abeja negra de Ouessant
CN102125512B (zh) 一种具有美白祛斑功能的组合物
EP2699223A2 (en) New cosmetic and therapeutical uses of ghk tripeptide
CN108852972A (zh) 一种天然护肤精华液及其制备方法
KR20240027604A (ko) 비타민 c 화합물을 함유하는 화장품 조성물 및 그의 사용
KR102062411B1 (ko) 아미노산 및 디올의 n-아실 유도체의 신규한 에스테르, 그 제조 방법, 및 화장품에서 및 약으로서의 그 용도
Musnaini et al. Effectiveness of cream formulation of carrot seed oil as anti-aging
JP2001115197A (ja) 石 鹸
CN101785752A (zh) 一种用于表皮修复的复合纳米乳及其制备方法
CN112402325A (zh) 红花多肽逆龄霜
KR100793825B1 (ko) 피부 각질 박리용 화장료 조성물
CN113876682B (zh) 一种珍珠粉自发泡洁面组合物及其制备方法和应用
DE202024000650U1 (de) Zusammensetzung zur Aufhellung der Haut
CN107440988A (zh) 一种保湿面膜
KR101134703B1 (ko) 훈자 살구 추출물을 함유하는 화장료 조성물
JP6666080B2 (ja) シワ改善方法、シワ改善機能向上方法、シワ改善用化粧料、シワ改善機能向上用化粧料、及びその使用、並びにシワ改善用化粧料の製造方法
RU2755199C1 (ru) Пенка для умывания
CN107823110A (zh) 一种温和修复精华液
CN108450956A (zh) 一种美容营养液
Vorster The quest for long term skin health